# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000078003-19-000021
Filing Date
2019-04-30
Accepted
2019-04-30 08:58:02
Documents
5
Period of Report
2019-04-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | pfe-03312019x8k.htm | 8-K | 31718
2 | EXHIBIT 99.1 | pfe-03312019xex99.htm | EX-99.1 | 1538002
3 |  | oldpfelogowhitea01a01a01a08.jpg | GRAPHIC | 95575
4 |  | pfizerbiopharmalogo.jpg | GRAPHIC | 754449
5 |  | upjohnlogo.jpg | GRAPHIC | 230605
| Complete submission text file | 0000078003-19-000021.txt |  | 3032732

Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 19778744
SIC: 2834 Pharmaceutical Preparations